Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with (177)Lu-DOTATATE

Peptide receptor radiotherapy (PRRT) with (177)Lu-DOTATATE has emerged as a promising therapy for neuroendocrine tumors (NETs). This retrospective cohort study aimed to assess the outcome of PRRT for 22 patients with histopathologically confirmed pheochromocytoma (PCC) and paraganglioma (PGL), of wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Vyakaranam, Achyut Ram, Crona, Joakim, Norlén, Olov, Granberg, Dan, Garske-Román, Ulrike, Sandström, Mattias, Fröss-Baron, Katarzyna, Thiis-Evensen, Espen, Hellman, Per, Sundin, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678507/
https://www.ncbi.nlm.nih.gov/pubmed/31261748
http://dx.doi.org/10.3390/cancers11070909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678507/
https://www.ncbi.nlm.nih.gov/pubmed/31261748
http://dx.doi.org/10.3390/cancers11070909

Ejemplares similares